IL131776A0 - Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes - Google Patents

Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes

Info

Publication number
IL131776A0
IL131776A0 IL13177698A IL13177698A IL131776A0 IL 131776 A0 IL131776 A0 IL 131776A0 IL 13177698 A IL13177698 A IL 13177698A IL 13177698 A IL13177698 A IL 13177698A IL 131776 A0 IL131776 A0 IL 131776A0
Authority
IL
Israel
Prior art keywords
temporal
oxidative stress
photodynamic therapy
heterologous genes
selective expression
Prior art date
Application number
IL13177698A
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL131776A0 publication Critical patent/IL131776A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
IL13177698A 1997-03-10 1998-03-09 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes IL131776A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81540297A 1997-03-10 1997-03-10
PCT/US1998/004551 WO1998040105A1 (en) 1997-03-10 1998-03-09 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes

Publications (1)

Publication Number Publication Date
IL131776A0 true IL131776A0 (en) 2001-03-19

Family

ID=25217693

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13177698A IL131776A0 (en) 1997-03-10 1998-03-09 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes

Country Status (10)

Country Link
EP (1) EP1005375A1 (en)
JP (1) JP2001514658A (en)
KR (1) KR20000076115A (en)
CN (1) CN1252006A (en)
AU (1) AU731502B2 (en)
CA (1) CA2283108A1 (en)
IL (1) IL131776A0 (en)
NZ (1) NZ337693A (en)
WO (1) WO1998040105A1 (en)
ZA (1) ZA981948B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811788B2 (en) * 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
US7927612B2 (en) 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
CA2714081C (en) * 2000-02-10 2013-08-06 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
CA2606858A1 (en) * 2005-05-03 2006-11-09 Veterinarmedizinische Universitat Wien Permeable capsules
CN101138634A (en) 2006-09-07 2008-03-12 于保法 Composition for treating tumour
CA2968853A1 (en) 2014-11-26 2016-06-02 Baofa Yu Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy
US20220313823A1 (en) * 2019-05-15 2022-10-06 Dong Sung Pharm. Co., Ltd. Photodynamic therapy method mediated by chlorin e6 photosensitizer composite for treating and preventing obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657111B2 (en) * 1990-12-20 1995-03-02 Dana-Farber Cancer Institute Control of gene expression by ionizing radiation
US5571797A (en) * 1994-05-11 1996-11-05 Arch Development Corporation Method of inducing gene expression by ionizing radiation

Also Published As

Publication number Publication date
CA2283108A1 (en) 1998-09-17
CN1252006A (en) 2000-05-03
AU731502B2 (en) 2001-03-29
NZ337693A (en) 2001-07-27
KR20000076115A (en) 2000-12-26
AU6453998A (en) 1998-09-29
WO1998040105A1 (en) 1998-09-17
ZA981948B (en) 1999-09-09
JP2001514658A (en) 2001-09-11
EP1005375A1 (en) 2000-06-07

Similar Documents

Publication Publication Date Title
PL325691A1 (en) Derivatives of dithiolane, method of obtaining them and their therapeutic effects
ZA982275B (en) Ultrasonic alternative to laser-based photodynamic therapy
IL139915A0 (en) Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
PL330235A1 (en) Derivatives of spiropiperidine and their application as therapeutic agents
NO985331D0 (en) Balloon catheter for photodynamic therapy
PL320952A1 (en) Cycloalkanon pyridines, method of obtaining and therapeutic agents containing them
GB9622500D0 (en) Therapeutic gene
EP0772678A4 (en) Modulation of drug radiation resistant genes
IL134718A0 (en) Treatment of conduct disorder
PL321201A1 (en) Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives
IL123716A0 (en) New therapeutic combinations of mirtazepine and an antipsychotic agent
IL131776A0 (en) Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
GB9719161D0 (en) New therapeutic method
EP1011661A4 (en) Mediation of circadian rhythms
HUP9904235A3 (en) Novel constructs and vectors for the targeted and inducible expression of genes
PL330550A1 (en) Novel aromatic ribose-substituted derivatives, method of obtaining them and their application as therapeutic agents
EP1009433A4 (en) Therapeutic composition and method of treatment
EP1070141A4 (en) Immediate early genes and methods of use therefor
GB2323284B (en) Device for photodynamic therapy of pituitary tumours
HUP9903603A3 (en) Balloon catheter for photodynamic therapy
GB9401011D0 (en) Expression of heterologous genes
TW294952U (en) Fixed safe armrest of elliptical trainer
TW335685U (en) Improved structure of heating therapy pad
GB9423368D0 (en) Gene therapy constructs